Experienced operator and investor focused on growth-stage technology and healthcare companies, Marion Hebert has blended corporate strategy, M&A and hands-on operating roles to source and scale businesses. Skilled at board-level governance, commercial go-to-market execution and capital formation, the profile suits PE/VC allocation, growth equity partnerships or corporate development mandates seeking operational depth and sector diligence.
Experienced operator and investor focused on growth-stage technology and healthcare companies, Marion Hebert has blended corporate strategy, M&A and hands-on operating roles to source and scale businesses. Skilled at board-level governance, commercial go-to-market execution and capital formation, the profile suits PE/VC allocation, growth equity partnerships or corporate development mandates seeking operational depth and sector diligence.
Operator-investor approach targeting growth-stage technology and healthcare businesses, prioritizing revenue-driven models with durable unit economics and scalable go-to-market motion. Allocates growth equity into companies where active board-level engagement and commercial execution accelerate value creation. Uses fundamental diligence, stage-aware risk-sizing and milestone-based capital tranches to preserve optionality; seeks 3–7 year liquidity windows and asymmetric upside through operational leverage.
Operator-investor approach targeting growth-stage technology and healthcare businesses, prioritizing revenue-driven models with durable unit economics and scalable go-to-market motion. Allocates growth equity into companies where active board-level engagement and commercial execution accelerate value creation. Uses fundamental diligence, stage-aware risk-sizing and milestone-based capital tranches to preserve optionality; seeks 3–7 year liquidity windows and asymmetric upside through operational leverage.
| Trades 1194 | Longs Won 824/1194 69% | Profit Factor 10.38 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $352,460.8 |
| Average Win $116,388.47 | Best Trade (Jul 16) $6.57M | Sharpe Ratio -9.55 |
| Average Loss -$24,981.61 | Worst Trade (Jul 16) -$831,201.6 | Z-Score 3.98 (100%) |
| Commissions $0 | Avg. Trade Length 11m 4w 1d | Expectancy $72,580.32 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 15,873 | 14,286 | 12,698 | 11,111 | 9,524 | 7,937 | 6,349 | 4,762 | 3,175 | 1,587 |